Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01847287 · ClinicalTrials.gov registry record
A Longitudinal Study of Brain Atrophy in MS Patients Over 5 Years
A clinical trial, sponsored by University at Buffalo.
- Completed
- Registry status
- 60
- Enrollment target
NCT01847287 is a clinical trial that has completed, run by University at Buffalo. The registered enrollment target is 60 participants.
The verdict
NCT01847287 has completed, sponsored by University at Buffalo.
- COMPLETED
- Registry status
- 60 participants
- Enrollment target
Study Summary
The primary aim of this study is to evaluate the effect of using Tysabri on changes in the brain using MRI and on disease progression in patients with relapsing-remitting Multiple Sclerosis over 5 years.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 60 participants |
| Start Date | 2012-05 |
| Est. Completion | 2013-02 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01847287
The ClinicalTrials.gov registry entry for NCT01847287 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 60 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University at Buffalo, which has 67 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 0 interventions.
NCT01847287 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01847287 about?
NCT01847287 is a clinical study titled "A Longitudinal Study of Brain Atrophy in MS Patients Over 5 Years". The primary aim of this study is to evaluate the effect of using Tysabri on changes in the brain using MRI and on disease progression in patients with relapsing-remitting Multiple Sclerosis over 5 years.
What is the current status of trial NCT01847287?
This trial is currently completed. The enrollment target is 60 participants. The study started on 2012-05. Estimated completion is 2013-02.
Who is sponsoring clinical trial NCT01847287?
This trial is sponsored by University at Buffalo, which has 67 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.